Matt Kaeberlein
Professor at University of Washington and chair of the American Aging Association
Matt Kaeberlein, Ph.D., is recognized globally for his research on the basic biology of aging. The premise of his research is that understanding the molecular mechanisms of aging will lead to interventions that slow the onset and progression of age-related chronic conditions, such as cancer, diabetes, kidney disease, heart disease, Alzheimer’s and others. Dr. Kaeberlein received his Ph.D. from the Massachusetts Institute of Technology in 2002 and performed his post-doctoral research in the Department of Genome Sciences at the University of Washington. Dr. Kaeberlein was appointed as an Assistant Professor of Pathology in 2006 and was promoted to Associate Professor in 2011.
Dr. Matt Kaeberlein is a Professor of Pathology, Adjunct Professor of Genome Sciences, and Adjunct Professor of Oral Health Sciences at the University of Washington. His research interests are focused on basic mechanisms of aging in order to facilitate translational interventions that promote healthspan and improve quality of life. He has published nearly 200 papers in top scientific journals and has been recognized by several prestigious awards, including a Breakthroughs in Gerontology Award, an Alzheimer’s Association Young Investigator Award, an Ellison Medical Foundation New Scholar in Aging Award, a Murdock Trust Award, a Pioneer in Aging Award, and the Vincent Cristofalo Rising Star in Aging Research.
Visit website: http://kaeberlein.org/matt-kaeberlein/
See also: 
University of Washington (UW)
- Public research university in Seattle, Washington
Matt Kaeberlein is also referenced in the following:
American Aging Association
Non-profit dedicated to biomedical aging studies, geroscience and slowing the aging process
BSRA Annual Scientific Meeting 2023
06-Sep-2023 to 08-Sep-2023
Jointly organised with the Biochemical Society - researcher disciplines include biochemistry, biology and medicine
Decoding Aging in Dogs (and Humans!)
25-May-2023
Decoding Longevity: Dogs, Humans, and the Shared Journey of Aging with Dr. Matt Kaeberlein by Oxford Society of Ageing and Longevity (FREE)
Dr. Matt Kaeberlein| Rapamycin, mTOR, Sirtuins, NAD+ & Dog Aging Project
Live Longer World podcast #5 with Dr. Matt Kaeberlein as a guest
Longevity Hackers
Feature length documentary about longevity and radical life extension with due to be released in 2023
Metabesity 2021
11-Oct-2021 to 14-Oct-2021
The Kitalys institute virtual conference targeting key questions that will impact the future of aging and extending healthspan
Rejuveron Age Better Live Longer Symposium
10-May-2022
Symposium about healthy living organized by Rejuveron (FREE)
Matt Kaeberlein News
Lifespan.io summarises the proceedings of the Buck Institute's Longevity Summit
Lifespan.io (LEAF) - 20-Jan-2023
Another reminder of the amount of research, with multiple approaches, about to go into clinical trials
Read more...Phase 2 clinical trial of lead drug candidate MYMD-1- a therapy for delaying aging
Business Wire - 26-Jul-2022
Sarcopenia drug trial shows no evidence of toxicity or safety issues
Read more...University of Washington launches Rapamycin Study
Live Forever Club - 05-Mar-2022
Have you been taking rapamycin supplements recently? Please consider contributing to this study.
Read more...First-ever true clinical trial to slow down ageing in dogs
Longevity Technology - 28-Sep-2021
A rapamycin trial testing healthspan improvements in dogs; results may extrapolate to humans as well
Read more...Dr. Matt Kaeberlein argues for more funding for geroscience
The Hill - 16-Jul-2021
Chair of American Aging Association disappointed ARPA-H may only receive half the requested funding
Read more...Recharge your mitochondrial batteries to live longer
Longevity Technology - 27-May-2021
Breakthrough in longevity research - cellular energetics may stop or even reverse the ageing process
Read more...Dog Aging Project invites participants to study canine health and longevity
University of Washington - 13-Apr-2021
Understanding the impact of genes, lifestyle, and environment on ageing
Read more...Stealthy Harvard startup wants to reverse aging
MIT Technology Review - 09-May-2018
Rejuvenate Bio is cofounded by George Church of Harvard Medical School. Will make animals “young...
Read more...Life extending drug tested on dogs
Deccan Chronicle - 15-Aug-2016
Anti-rejection drug rapamycin extend the life of mice by more than 25 per cent. If similar effec...
Read more...Articles written by Matt Kaeberlein
Dr. Matt Kaeberlein argues for more funding for geroscience
The Hill - 16-Jul-2021
Chair of American Aging Association disappointed ARPA-H may only receive half the requested funding
Read more...
